DonateJoin AFTINETVaccine Equity Campaign

TPP leak reveals harmful monopolies on medicines in Australia and globally

Public health expert Dr Deborah Gleeson says that many provisions  in the  TPP leaked text  will dramatically reduce access to affordable medicines, particularly in developing countries. While the Australian Government has said that the current law on 5-year data protection regime for costly biologics in Australia will not change, the text says that governments must deliver 'through other measures' an outcome comparable to eight years, meaning  an extra three years. .

TPP leak shows devil in the detail on access to biologic medicines and copyright monopolies

Media Release October 10, 2015

“The final version of the intellectual property chapter the TPP was leaked today on WikiLeaks with several technical analyses,” said Dr Patricia Ranald, Coordinator of the Australian Fair Trade and Investment Network.“Further analysis will take more time, but the text reveals that the US proposal for an extension of monopolies on costly life-saving biologic medicines from 5 to 8 years is still in the text,” said Dr Ranald.

Secret TPP deal lacks detail on medicines, investor rights to sue governments

Media Release October 6, 2015

“The announcement of a secret ‘in principle’ TPP deal without publication of the text may hide shameful trade-offs on issues like medicines and corporate rights to sue governments. These should be decided though open democratic parliamentary processes, not secretly traded away for token access to sugar or dairy markets, The lack of access to details in the text means governments can put a positive spin on the deal, but the devil is in the detail, and we won’t have the detail for at least another month,” said Dr Patricia Ranald, Coordinator of the Australian Fair Trade and Investment Network.

TPP talks: Robb should reject “death sentence” deal on medicines

MEDIA RELEASE  October 3, 2015                                                                                                                                               

"TPP negotiations in Atlanta, Georgia have been extended. The US has delayed its offers on market access for sugar and dairy products until the last minute, and is now pressuring Australia to agree to stronger monopolies which would delay affordable access to costly biologic medicines used to treat cancer, Trade Minister Robb should keep his promise and reject this shameful deal” Dr Patricia Ranald, Coordinator of the Australian Fair Trade and Investment Network said today. See full release here.

AFTINET RCEP second submission September 2015

September 2015: RCEP negotiations between Australia, New Zealand, China, Japan, South Korea, India and 10  ASEAN countries are now considering proposals for stronger monopolies on medicines and for foreign investor rights to sue governments over changes to domestic legislation, and aiming to finish the negotiations in 2016, AFTINET has done a second submission which addresses these issues in more detail.